TransMedics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

TransMedics Group (Nasdaq: TMDX) announced its management will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2020, at 5:20 p.m. EST. The company specializes in transforming organ transplant therapy through portable extracorporeal warm perfusion technology.

The presentation will be accessible live and in archive via the Investors section of their website.

ANDOVER, Mass., Dec. 24, 2020 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that members of the management team will present virtually at the upcoming 39^th Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 13, 2020 at 5:20 p.m. Eastern Standard Time.

Event: 39^th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 13, 2020
Time: 5:20 p.m. EST

A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/transmedics-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301198336.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics presenting at the J.P. Morgan Healthcare Conference?

TransMedics will present on January 13, 2020, at 5:20 p.m. EST.

Where can I watch the TransMedics presentation?

The presentation can be watched live and archived on the Investors section of the TransMedics website.

What is the significance of TransMedics Group in organ transplantation?

TransMedics is a leader in portable organ perfusion and assessment technologies, enhancing organ quality and viability for transplants.

What technology does TransMedics specialize in?

TransMedics specializes in portable extracorporeal warm perfusion technology for organ transplantation.

What is TMDX?

TMDX is the stock symbol for TransMedics Group, a company focused on organ transplant therapy.